From: SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma
Clinicopathologic parameters | SSX2IP expression level | P | |
---|---|---|---|
 | Low (n = 21) | High (n = 32) |  |
Gender | Â | Â | Â |
Female | 3 | 6 | 0.961 |
Male | 18 | 26 | Â |
Age | Â | Â | Â |
>50 | 11 | 19 | 0.615 |
≤50 | 10 | 13 |  |
Tumor size(cm) | Â | Â | Â |
>5 | 8 | 21 | 0.049 |
≤5 | 13 | 11 |  |
Tumor encapsulation | Â | Â | Â |
Complete | 13 | 16 | 0.394 |
Incomplete | 8 | 16 | Â |
Tumor differentiation | Â | Â | Â |
I II | 11 | 24 | 0.089 |
III IV | 10 | 8 | Â |
Tumor number | Â | Â | Â |
Single | 17 | 27 | 1.000 |
Multiple | 4 | 5 | Â |
Lymph node invasion | Â | Â | Â |
No | 20 | 29 | 0.928 |
Yes | 1 | 3 | Â |
Tumor thrombus | Â | Â | Â |
No | 18 | 18 | 0.025 |
Yes | 3 | 14 | Â |
AFP(ng/mL) | Â | Â | Â |
≤400 | 5 | 12 | 0.296 |
>400 | 16 | 20 | Â |